Health - Bloomberg
Skip to content
Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Customer SupportCustomer Support
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Products and Account Information
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
CompanyAboutCareersInclusion at BloombergTech at BloombergPhilanthropySustainabilityBloomberg Beta
CommunicationsPress AnnouncementsPress Contacts
FollowFacebookInstagramLinkedInYouTube
ProductsBloomberg TerminalDataTradingRiskComplianceIndices
Industry ProductsBloomberg LawBloomberg TaxBloomberg GovernmentBloombergNEF
MediaBloomberg MarketsBloomberg TechnologyBloomberg PursuitsBloomberg PoliticsBloomberg OpinionBloomberg BusinessweekBloomberg Live ConferencesBloomberg RadioBloomberg TelevisionNews Bureaus
Media ServicesBloomberg Media DistributionAdvertising
BloombergConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
For CustomersBloomberg Anywhere Remote LoginSoftware UpdatesManage Contracts and Orders
SupportAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000
Sign InSubscribeSearchLive TVMarketsChevron DownEconomicsIndustriesTechPoliticsBusinessweekOpinionMoreChevron DownUS EditionChevron DownMenuSubscribeHealthIndustriesEnergyEntertainmentFinanceConsumerReal EstateLegalTransportationTelecomSportsSpaceYuki Iwamura/BloombergNY May Need to Decouple to Avoid Federal Tax Law HitBloomberg OpinionBloomberg OpinionThis Crackdown on Drug Ads Is Long OverduePresident Trump’s order for tighter rules is a good start, but to succeed it needs tough enforcement and adequate resources.  By Lisa Jarvis, ColumnistDomestic Violence Is a Real Crime. My Mother Worked to Make It One.By Mary Ellen Klas, ColumnistAdvanced Prostate Cancer Is Rising. That’s Preventable.By Lisa Jarvis, ColumnistRFK Jr.’s Vision for the CDC Should Alarm CongressEditorial BoardSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.50 min ago50 min agoFired CDC Head to Say RFK Jr. Put Political Oversight on Policy5 hr ago5 hr agoTyson Foods to Eliminate Corn Syrup From Products by Year-End7 hr ago7 hr agoConceivable Raises $50 Million to Bring Robotic IVF Embryo Lab to US9 hr ago9 hr agoThe Boom in ‘Better for You’ Kid Snacks Is Worse for ParentsThey’re pricier. Nutritional claims are often laughable. And there’s no guarantee your children will eat them.10 hr ago10 hr agoWegovy Skin Side Effects Soar With Higher Dosage14 hr ago14 hr agoGerman Prosthetics Maker Ottobock Plans Fresh IPO Attempt14 hr ago14 hr agoA $3 Billion Plan to Bring Water to Johannesburg Hits SnagSeptember 13, 2025September 13, 2025Investors Bet $235 Million on Bringing AI to Scientific ResearchLila Sciences, which uses AI to develop novel drugs and materials, has received fresh funding led by Collective Global and Braidwell. September 12, 2025September 12, 2025Senator Calls for RFK. Jr. to Back Whooping Cough VaccinesSeptember 12, 2025September 12, 2025Busiest IPO Week Since 2021 Mints $4 Billion for Six NewcomersSeptember 12, 2025September 12, 2025AstraZeneca Pauses £200 Million Investment in UK HeadquartersSeptember 12, 2025September 12, 2025Drugmakers Fall on Report US to Claim Covid Shot Killed KidsSean Dong for Bloomberg BusinessweekHow Hims Became the King of Knockoff Weight-Loss DrugsBig Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no matter how risky it may be for the company.HomeBTV+Market DataOpinionAudioOriginalsMagazineEventsNewsMarketsEconomicsTechnologyPoliticsGreenCryptoAIWork & LifeWealthPursuitsBusinessweekCityLabSportsEqualityManagement & WorkMarket DataStocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic CalendarExploreNewslettersExplainersPointed News QuizThe Big TakeGraphicsSubmit a TipAbout UsTerms of ServiceDo Not Sell or Share My Personal InformationTrademarksPrivacy PolicyCareersMade in NYCAdvertiseAd ChoicesHelp©2025 Bloomberg L.P. All Rights Reserved.